Johan Karlsson Wallman (Johan A Karlsson, J K Wallman, Johan K Wallman, Johan Wallman)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 33

Top Topics

Rheumatoid Arthritis

Randomized Controlled Trial

Irritable Bowel Syndrome

Top Venues

The Journal of rheumatology

Annals of the rheumatic diseases

Arthritis care & research

ACR open rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore K Kvien, Daniela di Giuseppe, Johan Karlsson Wallman, Jakub Závada, Sella Aarrestad Provan, Eirik Klami Kristianslund, Ana Maria Rodrigues, Maria Jose Santos, Žiga Rotar, Katja Perdan Pirkmajer, Dan Nordström, Gary John Macfarlane, Gareth T Jones, Irene E van der Horst-Bruinsma, Pasoon Hellamand, Mikkel Østergaard, Merete Lund Hetland
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable? The Journal of rheumatology 51 (7) (2024)
Kristofer Andréasson, Tor Olofsson, Venu Lagishetty, Zaid Alrawi, Eline Klaassens, Savanne Holster, Roger Hesselstrand, Jonathan Patrick Jacobs, Johan Karlsson Wallman, Elizabeth R Volkmann
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota. ACR open rheumatology (2024)
Louise Linde, Stylianos Georgiadis, Lykke M Ørnbjerg, Simon H Rasmussen, Brigitte Michelsen, Johan Askling, Daniela Di Giuseppe, Johan Karlsson Wallman, Jakub Závada, Karel Pavelka, Miguel Bernardes, Carolina O Matos, Bente Glintborg, Anne Gitte Loft, Dan Nordström, Laura Kuusalo, Burkhard Möller, Michael J Nissen, Catalin Codreanu, Corina Mogosan, Bjorn Gudbjornsson, Thorvardur Jon Love, Cansu Akleylek, Florenzo Iannone, Tore K Kvien, Ziga Rotar, Isabel Castrejon, Gary John Macfarlane, Merete L Hetland, Mikkel Østergaard
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries. Arthritis care & research (2024)
Kristofer Andréasson, Tor Olofsson, Venu Lagishetty, Zaid Alrawi, Eline Klaassens, Savanne Holster, Roger Hesselstrand, Jonathan Patrick Jacobs, Johan Karlsson Wallman, Elizabeth R Volkmann
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota. ACR open rheumatology 6 (7) (2024)
Kristofer Andréasson, Tor Olofsson, Venu Lagishetty, Zaid Alrawi, Eline Klaassens, Savanne Holster, Roger Hesselstrand, Jonathan Patrick Jacobs, Johan Karlsson Wallman, Elizabeth R Volkmann
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota. ACR open rheumatology (2024)
Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore K Kvien, Daniela di Giuseppe, Johan Karlsson Wallman, Jakub Závada, Sella Aarrestad Provan, Eirik Klami Kristianslund, Ana Maria Rodrigues, Maria Jose Santos, Žiga Rotar, Katja Perdan Pirkmajer, Dan Nordström, Gary John Macfarlane, Gareth T Jones, Irene E van der Horst-Bruinsma, Pasoon Hellamand, Mikkel Østergaard, Merete Lund Hetland
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable? The Journal of rheumatology (2024)
Kristofer Andréasson, Tor Olofsson, Venu Lagishetty, Zaid Alrawi, Eline Klaassens, Savanne Holster, Roger Hesselstrand, Jonathan Patrick Jacobs, Johan Karlsson Wallman, Elizabeth R Volkmann
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota. ACR open rheumatology 6 (7) (2024)
Lykke Midtbøll Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, Simon Horskjær Rasmussen, Lennart Jacobsson, Anne Gitte Loft, Florenzo Iannone, Karen M Fagerli, Jiri Vencovsky, Maria Jose Santos, Burkhard Möller, Manuel Pombo-Suarez, Žiga Rotar, Bjorn Gudbjornsson, Ayse Cefle, Kari Eklund, Catalin Codreanu, Gareth T Jones, Marleen G H van de Sande, Johan Karlsson Wallman, Marco Sebastiani, Brigitte Michelsen, Jakub Závada, Michael John Nissen, Carlos Sánchez-Piedra, Matija Tomšič, Thorvardur Jon Love, Heikki Relas, Corina Mogosan, Merete Lund Hetland, Mikkel Østergaard
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care. The Journal of rheumatology 51 (4) (2024)
Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore K Kvien, Daniela di Giuseppe, Johan Karlsson Wallman, Jakub Závada, Sella Aarrestad Provan, Eirik Klami Kristianslund, Ana Maria Rodrigues, Maria Jose Santos, Žiga Rotar, Katja Perdan Pirkmajer, Dan Nordström, Gary John Macfarlane, Gareth T Jones, Irene E van der Horst-Bruinsma, Pasoon Hellamand, Mikkel Østergaard, Merete Lund Hetland
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable? The Journal of rheumatology 51 (7) (2024)
Kristofer Andréasson, Tor Olofsson, Venu Lagishetty, Zaid Alrawi, Eline Klaassens, Savanne Holster, Roger Hesselstrand, Jonathan Patrick Jacobs, Johan Karlsson Wallman, Elizabeth R Volkmann
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota. ACR open rheumatology 6 (7) (2024)
Lykke Midtbøll Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, Simon Horskjær Rasmussen, Lennart Jacobsson, Anne Gitte Loft, Florenzo Iannone, Karen M Fagerli, Jiri Vencovsky, Maria Jose Santos, Burkhard Möller, Manuel Pombo-Suarez, Žiga Rotar, Bjorn Gudbjornsson, Ayse Cefle, Kari Eklund, Catalin Codreanu, Gareth T Jones, Marleen G H van de Sande, Johan Karlsson Wallman, Marco Sebastiani, Brigitte Michelsen, Jakub Závada, Michael John Nissen, Carlos Sánchez-Piedra, Matija Tomšič, Thorvardur Jon Love, Heikki Relas, Corina Mogosan, Merete Lund Hetland, Mikkel Østergaard
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care. The Journal of rheumatology 51 (4) (2024)
Olafur Palsson, Thorvardur Jon Love, Johan Karlsson Wallman, Meliha Crnkic Kapetanovic, P S Gunnarsson, Bjorn Gudbjornsson
Prescription of non-steroidal anti-inflammatory drugs for patients with inflammatory arthritis decreases with the initiation of tumour necrosis factor inhibitor therapy: results from the ICEBIO registry. Scandinavian journal of rheumatology (2024)
Louise Linde, Stylianos Georgiadis, Lykke M Ørnbjerg, Simon H Rasmussen, Brigitte Michelsen, Johan Askling, Daniela Di Giuseppe, Johan Karlsson Wallman, Jakub Závada, Karel Pavelka, Miguel Bernardes, Carolina O Matos, Bente Glintborg, Anne Gitte Loft, Dan Nordström, Laura Kuusalo, Burkhard Möller, Michael J Nissen, Catalin Codreanu, Corina Mogosan, Bjorn Gudbjornsson, Thorvardur Jon Love, Cansu Akleylek, Florenzo Iannone, Tore K Kvien, Ziga Rotar, Isabel Castrejon, Gary John Macfarlane, Merete L Hetland, Mikkel Østergaard
Comparing DAPSA, DAPSA28 and DAS28-CRP in patients with psoriatic arthritis initiating a first TNF-inhibitor across nine European countries. Arthritis care & research (2024)
Pasoon Hellamand, Marleen G H van de Sande, Michael T Nurmohamed, Ronald F Van Vollenhoven, Rosemary J Hollick, Ovidiu Rotariu, Žiga Rotar, Katja Perdan Pirkmajer, Dan Nordström, Anna-Mari Hokkanen, Brigitte Michelsen, Tore K Kvien, Bente Glintborg, Merete Lund Hetland, Mikkel Østergaard, Anne Gitte Loft, Karel Pavelka, Jakub Závada, Isabel Castrejon, Lucia Otero Varela, Bjorn Gudbjornsson, Olafur Palsson, Tor Olofsson, Johan Karlsson Wallman, Adrian Ciurea, Michael John Nissen, Tuba D Yildirim, Fatoş Önen, Catalin Codreanu, Corina Mogosan, Maria Jose Santos, Elsa Viera Sousa, Florenzo Iannone, Bruno Frediani, Lykke Midtbøll Ørnbjerg, Jos W R Twisk, Irene E van der Horst-Bruinsma
Sex differences in patient-reported outcomes and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors. Rheumatology (Oxford, England) (2024)
Sofia Exarchou, Daniela Di Giuseppe, Eva Klingberg, Valgerdur Sigurdardottir, Sara Wedrén, Ulf Lindström, Carl Turesson, Lennart T H Jacobsson, Johan Askling, Johan Karlsson Wallman
Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study. Annals of the rheumatic diseases (2023)
Pasoon Hellamand, Marleen G H van de Sande, Lykke M Ørnbjerg, Thomas Klausch, Kari K Eklund, Heikki Relas, Maria Jose Santos, Elsa Vieira-Sousa, Anne Gitte Loft, Bente Glintborg, Mikkel Østergaard, Ulf Lindström, Johan Karlsson Wallman, Brigitte Michelsen, Karen M Fagerli, Isabel Castrejon, Bjorn Gudbjornsson, Thorvardur J Love, Jiří Vencovský, Lucie Nekvindová, Žiga Rotar, Matija Tomšič, Federico Díaz-González, Gökce Kenar, Handan Y Tuğsal, Florenzo Iannone, Roberta Ramonda, Catalin Codreanu, Corina Mogosan, Michael J Nissen, Burkhard Möller, Merete L Hetland, Irene E van der Horst-Bruinsma
Sex differences in the effectiveness of first-line tumor necrosis factor inhibitors in psoriatic arthritis; results from the EuroSpA Research Collaboration Network. Arthritis & rheumatology (Hoboken, N.J.) (2023)
C Roseman, Johan Karlsson Wallman, Anna Jöud, Maria E C Schelin, Jon Thorkell Einarsson, Elisabet Lindqvist, Jon Lampa, Meliha Crnkic Kapetanovic, Tor Olofsson
Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control? Scandinavian journal of rheumatology (2023)
Bente Glintborg, Daniela Di Giuseppe, Johan Karlsson Wallman, Dan C Nordström, Bjorn Gudbjornsson, Merete Lund Hetland, Johan Askling, Gerdur Grondal, Tuulikki Sokka, Sella Aarrestad Provan, Brigitte Michelsen, Eirik Klami Kristianslund, Lene Dreyer, Thorvardur Jon Love, Ulf Lindström
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries. Annals of the rheumatic diseases (2023)
Elisabet Lindqvist, Tor Olofsson, Anna Jöud, Mats Geijer, Johan Karlsson Wallman, Elisabeth Mogard
How good is the agreement between clinical diagnoses and classification criteria fulfilment in axial spondyloarthritis? Results from the SPARTAKUS cohort. Scandinavian journal of rheumatology (2022)
Viggo Hamberg, Johan Karlsson Wallman, Elisabeth Mogard, Elisabet Lindqvist, Tor Olofsson, Kristofer Andréasson
Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis. Rheumatology international (2022)
Johan Karlsson Wallman, G-M Alenius, Eva Klingberg, Valgerdur Sigurdardottir, S Wedrén, Sofia Exarchou, Ulf Lindström, Daniela di Giuseppe, Johan Askling, Lennart T H Jacobsson
Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register. Scandinavian journal of rheumatology (2022)
Tor Olofsson, Johan Karlsson Wallman, Anna Jöud, Maria E C Schelin, Sofia Ernestam, Ronald van Vollenhoven, Saedis Saevarsdottir, Jon Lampa
Pain Over Two Years After Start of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: Results From a Swedish Randomized Controlled Trial. Arthritis care & research 73 (9) (2021)
Heather Miller, Johan Karlsson Wallman, Ingemar F Petersson, Saedis Saevarsdottir, Jonas Söderling, Sofia Ernestam, Johan Askling, Ronald van Vollenhoven, Martin Neovius
Mortality over 14 years in MTX-refractory patients randomized to a strategy of addition of infliximab or sulfasalazine and hydroxychloroquine. Rheumatology (Oxford, England) 60 (5) (2021)
Ulf Lindström, Bente Glintborg, Daniela di Giuseppe, Tanja Schjødt Jørgensen, Bjorn Gudbjornsson, Kathrine Lederballe Grøn, Sella Aarrestad Provan, Brigitte Michelsen, Merete Lund Hetland, Johan Karlsson Wallman, Dan Nordström, Nina Trokovic, Thorvardur Jon Love, Niels Steen Krogh, Johan Askling, Lennart T H Jacobsson, Lars Erik Kristensen
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis. Rheumatology (Oxford, England) 60 (8) (2021)
Brigitte Michelsen, Stylianos Georgiadis, Daniela Di Giuseppe, Anne G Loft, Michael J Nissen, Florenzo Iannone, Manuel Pombo-Suarez, Herman Mann, Ziga Rotar, Kari K Eklund, Tore K Kvien, Maria Jose Santos, Bjorn Gudbjornsson, Catalin Codreanu, Sema Yilmaz, Johan Karlsson Wallman, Cecilie H Brahe, Burkhard Möller, Ennio G Favalli, Carlos Sánchez-Piedra, Lucie Nekvindova, Matija Tomsic, Nina Trokovic, Eirik K Kristianslund, Helena Santos, Thorvardur J Löve, Ruxandra Ionescu, Yavuz Pehlivan, Gareth T Jones, Irene van der Horst-Bruinsma, Lykke M Ørnbjerg, Mikkel Østergaard, Merete L Hetland
Real-world 6 and 12-month Drug Retention, Remission and Response Rates of Secukinumab in 2,017 Psoriatic Arthritis patients in 13 European Countries. Arthritis care & research (2021)
Annelies Boonen, Polina Putrik, Mary Lucy Marques, Alessia Alunno, Lydia Abasolo, Dorcas Beaton, Neil Betteridge, Mathilda Bjørk, Maarten Boers, Boryana Boteva, Bruno Fautrel, Francis Guillemin, Elsa F Mateus, Elena Nikiphorou, Márta Péntek, Fernando Pimentel Santos, Johannes L Severens, Suzanne M M Verstappen, Karen Walker-Bone, Johan Karlsson Wallman, Marieke M Ter Wee, René Westhovens, Josef S Smolen
EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis. Annals of the rheumatic diseases 80 (9) (2021)
Elisabeth Mogard, Tor Olofsson, Stefan Bergman, Ann Bremander, Lars Erik Kristensen, Jack Kvistgaard Olsen, Johan Karlsson Wallman, Elisabet Lindqvist
Chronic Pain and Assessment of Pain Sensitivity in Patients With Axial Spondyloarthritis: Results From the SPARTAKUS Cohort. The Journal of rheumatology 48 (11) (2020)
Bente Glintborg, Ulf Lindström, Daniela Di Giuseppe, Sella Aarrestad Provan, Bjorn Gudbjornsson, Merete Lund Hetland, Brigitte Michelsen, Johan Karlsson Wallman, Kalle Aaltonen, Anna-Mari Hokkanen, Dan Nordström, Tanja Schjødt Jørgensen, Rebekka Lund Hansen, Arni Jon Geirsson, Kathrine Grøn, Niels Steen Krogh, Johan Askling, Lars Erik Kristensen, Lennart Jacobsson, null null
One-year treatment outcomes of secukinumab versus tumor necrosis factor inhibitors in Spondyloarthritis. Arthritis care & research (2020)
Tor Olofsson, Jonas K Söderling, Anders Gülfe, Lars-Erik Kristensen, Johan Karlsson Wallman
Patient-Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics-Treated Patients With Rheumatoid Arthritis. Arthritis care & research 70 (11) (2019)
Johan Karlsson Wallman, Elisabeth Mogard, Jan Marsal, Kristofer Andréasson, Anna Jöud, Mats Geijer, Lars Erik Kristensen, Elisabet Lindqvist, Tor Olofsson
Response to: 'response to: irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?' by Proft et al. Annals of the rheumatic diseases (2019)
Johan Karlsson Wallman, Elisabeth Mogard, Jan Marsal, Kristofer Andréasson, Anna Jöud, Mats Geijer, Lars Erik Kristensen, Elisabet Lindqvist, Tor Olofsson
Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity? Annals of the rheumatic diseases 79 (1) (2019)
Suzanne M M Verstappen, Diane Lacaille, Annelies Boonen, Reuben Escorpizo, Catherine Hofstetter, Ailsa Bosworth, Amye Leong, Sarah A Leggett, Monique A M Gignac, Johan Karlsson Wallman, Marieke M Ter Wee, Florian Berghea, Maria Agaliotis, Peter Tugwell, Dorcas Beaton
Considerations for Evaluating and Recommending Worker Productivity Outcome Measures: An Update from the OMERACT Worker Productivity Group. The Journal of rheumatology 46 (10) (2019)
Karen Hambardzumyan, Rebecca J Bolce, Johan Karlsson Wallman, Ronald F Van Vollenhoven, Saedis Saevarsdottir
Serum Biomarkers for Prediction of Response to Methotrexate Monotherapy in Early Rheumatoid Arthritis: Results from the SWEFOT Trial. The Journal of rheumatology 46 (6) (2019)
Alf Kastbom, Kristina Forslind, Sofia Ernestam, Pierre Geborek, Johan Karlsson Wallman, Ingemar F Petersson, Saedis Saevarsdottir, Lars Klareskog, Ronald F van Vollenhoven, Karin Lundberg
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial. Annals of the rheumatic diseases 75 (2) (2014)